
New nonprofit aims to make rare-disease gene therapy routine instead of bespoke
It wants to standardize treatments for conditions pharma historically avoided, changing incentives for developers, payers, and regulators.
By Hessa Al-Faleh·· 3 min

Curating from trusted global sources…
2 briefings · “developers”

It wants to standardize treatments for conditions pharma historically avoided, changing incentives for developers, payers, and regulators.

Open-weight AI is not open-source economics, and that mismatch is crushing model makers while powering cloud operators.